Remdesivir-d4

Cat. No.: IBDI-436863

Remdesivir-d4 is deuterium labeled Remdesivir. Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity, has EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro.

Product Details

Target	DNA/RNA Synthesis | SARS-CoV
Molecular Weight	606.60
Synonyms	GS-5734-d4
SMILES	O=C(OCC(CC)CC)[[email protected]@](C([2H])([2H])[2H])([2H])N[[email protected]@](OC1=CC=CC=C1)(OC[[email protected]]2O[[email protected]@](C#N)(C3=CC=C4C(N)=NC=NN43)[[email protected]](O)[[email protected]@H]2O)=O

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.